PBYI logo

Puma Biotechnology (PBYI) Operating Profit

Annual Operating Profit

$33.27 M
+$2.54 M+8.28%

December 31, 2023


Summary


Performance

PBYI Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPBYIprofitabilitymetrics:

Quarterly Operating Profit

$22.08 M
+$24.26 M+1113.26%

September 30, 2024


Summary


Performance

PBYI Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPBYIprofitabilitymetrics:

TTM Operating Profit

$32.40 M
+$12.87 M+65.89%

September 30, 2024


Summary


Performance

PBYI TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPBYIprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

PBYI Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8.3%+139.7%+13.8%
3 y3 years+209.4%+83.1%+252.6%
5 y5 years+135.1%+83.1%+252.6%

PBYI Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+2478.7%at high+1060.4%-9.6%+266.1%
5 y5-yearat high+185.2%at high+232.7%-9.6%+151.3%
alltimeall timeat high+111.4%at high+128.2%-9.6%+110.7%

Puma Biotechnology Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
$22.08 M(-1113.3%)
$32.40 M(+65.9%)
Jun 2024
-
-$2.18 M(-5.2%)
$19.53 M(-26.6%)
Mar 2024
-
-$2.30 M(-115.5%)
$26.60 M(-20.0%)
Dec 2023
$33.27 M(+8.3%)
$14.80 M(+60.7%)
$33.27 M(+16.8%)
Sep 2023
-
$9.21 M(+88.3%)
$28.48 M(-0.6%)
Jun 2023
-
$4.89 M(+12.1%)
$28.67 M(-20.0%)
Mar 2023
-
$4.37 M(-56.4%)
$35.83 M(+16.6%)
Dec 2022
$30.72 M(+2281.4%)
$10.02 M(+6.6%)
$30.72 M(+11.6%)
Sep 2022
-
$9.39 M(-22.1%)
$27.54 M(+199.7%)
Jun 2022
-
$12.06 M(-1714.2%)
$9.19 M(-147.1%)
Mar 2022
-
-$747.00 K(-110.9%)
-$19.50 M(-1502.0%)
Dec 2021
$1.29 M(-104.2%)
$6.83 M(-176.3%)
$1.39 M(-108.4%)
Sep 2021
-
-$8.95 M(-46.2%)
-$16.59 M(-16.1%)
Jun 2021
-
-$16.63 M(-182.6%)
-$19.77 M(-594.8%)
Mar 2021
-
$20.15 M(-280.7%)
$4.00 M(-113.1%)
Dec 2020
-$30.40 M(-22.1%)
-$11.15 M(-8.1%)
-$30.40 M(+8.9%)
Sep 2020
-
-$12.13 M(-270.2%)
-$27.92 M(-7.7%)
Jun 2020
-
$7.13 M(-150.0%)
-$30.23 M(-52.1%)
Mar 2020
-
-$14.25 M(+64.5%)
-$63.14 M(+61.7%)
Dec 2019
-$39.05 M(-58.8%)
-$8.66 M(-40.0%)
-$39.05 M(-20.2%)
Sep 2019
-
-$14.45 M(-44.0%)
-$48.92 M(+6.9%)
Jun 2019
-
-$25.78 M(-361.8%)
-$45.75 M(-25.5%)
Mar 2019
-
$9.85 M(-153.1%)
-$61.41 M(-35.1%)
Dec 2018
-$94.66 M(-67.6%)
-$18.54 M(+64.3%)
-$94.66 M(-32.2%)
Sep 2018
-
-$11.28 M(-72.8%)
-$139.69 M(-32.1%)
Jun 2018
-
-$41.44 M(+77.2%)
-$205.84 M(-15.1%)
Mar 2018
-
-$23.39 M(-63.2%)
-$242.58 M(-17.0%)
Dec 2017
-$292.39 M(+5.7%)
-$63.57 M(-17.9%)
-$292.39 M(-3.1%)
Sep 2017
-
-$77.44 M(-0.9%)
-$301.69 M(+3.9%)
Jun 2017
-
-$78.18 M(+6.8%)
-$290.25 M(+4.2%)
Mar 2017
-
-$73.20 M(+0.5%)
-$278.55 M(+0.7%)
Dec 2016
-$276.60 M
-$72.87 M(+10.4%)
-$276.60 M(+4.1%)
Sep 2016
-
-$66.00 M(-0.7%)
-$265.76 M(+2.0%)
DateAnnualQuarterlyTTM
Jun 2016
-
-$66.48 M(-6.7%)
-$260.50 M(+0.6%)
Mar 2016
-
-$71.25 M(+14.8%)
-$258.93 M(+7.8%)
Dec 2015
-$240.28 M(+68.9%)
-$62.03 M(+2.1%)
-$240.28 M(+6.4%)
Sep 2015
-
-$60.73 M(-6.4%)
-$225.84 M(+12.3%)
Jun 2015
-
-$64.91 M(+23.4%)
-$201.06 M(+14.9%)
Mar 2015
-
-$52.60 M(+10.5%)
-$175.06 M(+23.0%)
Dec 2014
-$142.28 M(+159.5%)
-$47.59 M(+32.4%)
-$142.28 M(+28.6%)
Sep 2014
-
-$35.96 M(-7.6%)
-$110.67 M(+24.3%)
Jun 2014
-
-$38.91 M(+96.3%)
-$89.04 M(+41.7%)
Mar 2014
-
-$19.82 M(+24.0%)
-$62.85 M(+14.6%)
Dec 2013
-$54.83 M(-26.3%)
-$15.99 M(+11.6%)
-$54.83 M(-9.8%)
Sep 2013
-
-$14.33 M(+12.8%)
-$60.79 M(-16.0%)
Jun 2013
-
-$12.71 M(+7.6%)
-$72.33 M(-2.8%)
Mar 2013
-
-$11.81 M(-46.2%)
-$74.40 M(-0.1%)
Dec 2012
-$74.45 M(+633.0%)
-$21.95 M(-15.2%)
-$74.45 M(+19.5%)
Sep 2012
-
-$25.87 M(+75.1%)
-$62.29 M(+69.5%)
Jun 2012
-
-$14.78 M(+24.7%)
-$36.75 M(+67.0%)
Mar 2012
-
-$11.85 M(+21.1%)
-$22.01 M(+116.6%)
Dec 2011
-$10.16 M(>+9900.0%)
-$9.78 M(+2830.5%)
-$10.16 M(+2654.1%)
Sep 2011
-
-$333.90 K(+873.5%)
-$368.80 K(+868.0%)
Jun 2011
-
-$34.30 K(+779.5%)
-$38.10 K(+514.5%)
Mar 2011
-
-$3900.00(-218.2%)
-$6200.00(-11.4%)
Dec 2010
-$7000.00(-58.3%)
$3300.00(-203.1%)
-$7000.00(-48.5%)
Sep 2010
-
-$3200.00(+33.3%)
-$13.60 K(-0.7%)
Jun 2010
-
-$2400.00(-48.9%)
-$13.70 K(-11.6%)
Mar 2010
-
-$4700.00(+42.4%)
-$15.50 K(-7.7%)
Dec 2009
-$16.80 K(+19.1%)
-$3300.00(0.0%)
-$16.80 K(+7.0%)
Sep 2009
-
-$3300.00(-21.4%)
-$15.70 K(-4.3%)
Jun 2009
-
-$4200.00(-30.0%)
-$16.40 K(+5.1%)
Mar 2009
-
-$6000.00(+172.7%)
-$15.60 K(+10.6%)
Dec 2008
-$14.10 K
-$2200.00(-45.0%)
-$14.10 K(+18.5%)
Sep 2008
-
-$4000.00(+17.6%)
-$11.90 K(+50.6%)
Jun 2008
-
-$3400.00(-24.4%)
-$7900.00(+75.6%)
Mar 2008
-
-$4500.00
-$4500.00

FAQ

  • What is Puma Biotechnology annual operating income?
  • What is the all time high annual operating profit for Puma Biotechnology?
  • What is Puma Biotechnology annual operating profit year-on-year change?
  • What is Puma Biotechnology quarterly operating income?
  • What is the all time high quarterly operating profit for Puma Biotechnology?
  • What is Puma Biotechnology quarterly operating profit year-on-year change?
  • What is Puma Biotechnology TTM operating income?
  • What is the all time high TTM operating profit for Puma Biotechnology?
  • What is Puma Biotechnology TTM operating profit year-on-year change?

What is Puma Biotechnology annual operating income?

The current annual operating profit of PBYI is $33.27 M

What is the all time high annual operating profit for Puma Biotechnology?

Puma Biotechnology all-time high annual operating income is $33.27 M

What is Puma Biotechnology annual operating profit year-on-year change?

Over the past year, PBYI annual operating income has changed by +$2.54 M (+8.28%)

What is Puma Biotechnology quarterly operating income?

The current quarterly operating profit of PBYI is $22.08 M

What is the all time high quarterly operating profit for Puma Biotechnology?

Puma Biotechnology all-time high quarterly operating income is $22.08 M

What is Puma Biotechnology quarterly operating profit year-on-year change?

Over the past year, PBYI quarterly operating income has changed by +$12.87 M (+139.73%)

What is Puma Biotechnology TTM operating income?

The current TTM operating profit of PBYI is $32.40 M

What is the all time high TTM operating profit for Puma Biotechnology?

Puma Biotechnology all-time high TTM operating income is $35.83 M

What is Puma Biotechnology TTM operating profit year-on-year change?

Over the past year, PBYI TTM operating income has changed by +$3.92 M (+13.75%)